Research on the Influence of Government R&D Funding and Enterprise R&D Investment on the Innovation Efficiency of Pharmaceutical Industry  

作　　者：Zhang Xuefeng Jia Zheng Fu Shuyong Zhang Dawei Xing Hua 

机构地区：[1]School of Business Administration,Shenyang Pharmaceutical University,Shenyang 110016,China [2]Tangshan Vocational Technical College,Tangshan 063000,China

出　　处：《Asian Journal of Social Pharmacy》2024年第4期361-370,共10页亚洲社会药学（英文）

基　　金：Liaoning Science Public Welfare Research Fund(Soft Science Research Program)in 2022(No.2022JH4/10100040).

摘　　要：Objective To study the effect of government R&D funding and enterprise R&D input on innovation efficiency of China’s pharmaceutical industry.Methods Based on the inter-provincial panel data of China’s pharmaceutical industry from 2009 to 2019,the stochastic frontier analysis method was used to study the influence of government R&D funding and enterprise R&D input on the innovation efficiency.Results and Conclusion With 1%increase in government R&D funding,the innovation efficiency of enterprises will increase by 0.122%.When R&D investment increases by 1%,innovation efficiency will increase by 0.169%.Both government R&D funding and enterprise R&D investment promote the innovation efficiency of pharmaceutical enterprises,but the increase of enterprise R&D investment contributes more to the improvement of pharmaceutical innovation efficiency.

关 键 词：government R&D funding enterprise R&D investment pharmaceutical industry enterprise innovation efficiency stochastic frontier analysis 

分 类 号：R95[医药卫生—药学]